Charles A. Peloquin, PharmD


Individualized Beta-Lactam Therapy and Monitoring

Elevated beta-lactam concentrations have been associated with neurotoxic adverse effects, including seizures and mental status changes.

Jaime Rosenberg


Estimating HIV Screening Incidence Among US Citizens

Investigators used national electronic health record data to determine the proportion of American adults who have been tested for HIV.

Payal Patel, MD, MPH


Coffee, Donuts, and Antimicrobial Stewardship

Targeting stewardship interventions to the morning hours may have a greater impact than afternoons and nights.

Grant M. Gallager


Systematic Review Highlights Hydroxychloroquine Ambiguities

Investigators sought to summarize evidence about the benefits and harms of hydroxychloroquine and chloroquine as treatments or prophylaxis of COVID-19.

David Cluck, PharmD, BCPS, AAHIVP


Guidelines to Caring for Patients With Sepsis: Promise or Progress?

Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.

George Sakoulas, MD


Key Takeaways on Managing ABSSSI

George Sakoulas, MD, shares key takeaways on soft tissue infections from ID week 2023.

Laurie Toich


Teva Pharmaceuticals Announces Launch of Generic HIV Drug

Teva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.

Rachel Britt, PharmD*


Entering the Ring: Oral Vancomycin Versus Metronidazole for C difficile Infection and the Risk of Vancomycin-Resistant Enterococcus

In 2017, a guideline update stripped metronidazole of its first-line therapy designation and crowned oral vancomycin as initial therapy for all C difficile infection cases.

Alexander R. Evens, DO


Integrating Order Sets Into Antimicrobial Stewardship Strategies

Since its implementation in December 2016, use of a ceftolozane-tazobactam order set at Marin General Hospital has advanced antimicrobial stewardship efforts.

Peter L. Salgo, MD


Final Thoughts on COVID-19 and Flu

Final thoughts from experts on controlling COVID-19 and influenza.

William R. Short, MD, MPH, AAHIVS


Rapid ART Initiation: A New Model Presents Unique Opportunities and Challenges

Patients with a new diagnosis of HIV may benefit from rapid start of ART.



Long-Acting Anti-MRSA Agents: One Dose to Cure?

A review of the current literature and future directions.

Julia Schiff, MD, MPH


A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent Host

Quick recognition is key to early initiation of treatment and long-term survival.

Krutika N. Mediwala, PharmD, BCPS, BCIDP


Utilizing MRSA Nasal Screening for Antimicrobial Stewardship

This In the Literature piece details a study evaluating MRSA nasal screening’s effect on antimicrobial stewardship.

David Cluck, PharmD


A New Meaning to "Getting Tested"

Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.



An Unexpected Meningitis Culprit

A team of physicians yields surprising findings in an elderly patient in shock with seizures.

Mike Hennessy Sr


The Future of Health Care After COVID-19

My hope is that years from now, when we look back on the coronavirus disease 2019 (COVID-19) pandemic, it will have served a few purposes.

Bill Schu


Neglect of Skin Wounds Is a Risk Factor for Becoming a Carrier of S. Aureus

A new study in BMC Public Health finds that neglect of skin wounds is an independent and strong risk factor for becoming a carrier of Staphylococcus aureus (S. aureus), a dangerous pathogen that can cause infections and lead to life-threatening infectious diseases.

Krista Gens, PharmD, BCPS-AQ-ID


The Great Debate: Polymyxin B Versus Polymyxin E

As we await novel compounds from a relatively apathetic industry, we are resurrecting antibiotics of which we have an outdated understanding. and that carry the potential for substantial side effects: polymyxins.

Kenneth Bender, PharmD, MA


Inhaled Amikacin Reduces Risk of Ventilator-Associated Pneumonia

Amikacin inhaled once daily for 3 days reduced risk of developing ventilator-associated pneumonia in placebo-controlled trial in critically ill.

Madeline King, PharmD, BCIDP*


Future of Fluoroquinolones: Risks, Benefits of Antibiotic Workhorse

Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS


Final Thoughts on COVID-19 and Flu

Final thoughts from experts on controlling COVID-19 and influenza.

Saskia v. Popescu


Addressing ART Adherence in Hispanic/Latino Men Living with HIV

Investigators found these populations are younger and are living at or below poverty were at lower adherence to ART.

Alan Gross, PharmD, BCPS-AQ-ID


A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.

Catherine Kolonko


Testing Still Needed After HCV Clears in HIV-Positive MSM

A retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.

Lucia Rose, PharmD, BCIDP


Lefamulin: An Overview of a Lonely Soldier

Lefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.

Panelist: Thomas Lodise, PharmD, PhD


IDWeek 2019 News Network: Assessing Challenges to Treating CABP

Thomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.

© 2023 MJH Life Sciences

All rights reserved.